drugset / Trial / NCT02067676
Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea
Phase 1
Completed
48 enrolled
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR) · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the safety of increasing doses of a potential vaccine against Campylobacter with and without Alhydrogel®, an aluminum hydroxide adjuvant. This study will also assess immune responses induced by the vaccine.
Timeline
- Start
- 2014-04-21
- Primary completion
- 2014-09-24
- Completion
- 2016-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aluminum hydroxide | Unknown | 125 ug | Intramuscular |
| Subject | CJCV1 | Vaccine | 2 ug | Intramuscular |
| Subject | CJCV1 | Vaccine | 5 ug | Intramuscular |
| Subject | CJCV1 | Vaccine | 10 ug | Intramuscular |